Sirtratumab
Sirtratumab is a human IgG2 monoclonal antibody against SLIT and NTRK-like family 6 (Slitrk6) . Sirtratumab can be used in research of cancer[1].
Product Specifications
CAS Number
[1824663-82-2]
Product Name Alternative
AGS15C; Ha15-10ac12; Ha15-10ac12.1
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sirtratumab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Sirtratumab]
Molecular Weight
(146 kDa)
References & Citations
[1]D'Angelo A, et, al. An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes next. Cancer Chemother Pharmacol. 2022 Sep;90 (3) :191-205.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1364245-01 0.02 mg (E-Coli)
Recombinant Salmonella paratyphi A 3-ketoacyl-CoA thiolase (fadA)
Ask
View Details MBS1364245-02 0.02 mg (Yeast)
Recombinant Salmonella paratyphi A 3-ketoacyl-CoA thiolase (fadA)
Ask
View Details 
MBS1364245-03 0.1 mg (E-Coli)
Recombinant Salmonella paratyphi A 3-ketoacyl-CoA thiolase (fadA)
Ask
View Details MBS1364245-04 0.1 mg (Yeast)
Recombinant Salmonella paratyphi A 3-ketoacyl-CoA thiolase (fadA)
Ask
View Details